Supplementary Information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
The remaining drug can be continuously released for several months
It grades withdrawal severity from 0 to 36 points on measures including pulse, pupillary size, restlessness, and yawning (Wesson DR and Ling W, J Psychoactive Drugs 2003;35(2):253259)
Chemotherapy Recovery Enhancement Preliminary Research Research demonstrates FOXO4-DRI's potential to accelerate recovery from chemotherapy-induced damage by eliminating senescent cells that accumulate following cytotoxic cancer treatment and contribute to long-term side effects